石四药集团(02005)：呋塞米获国家药监局批准登记成为在上市制剂使用的原料药

智通财经04-21

智通财经APP讯，石四药集团(02005)发布公告，本集团的呋塞米已获中国国家药品监督管理局(国家药监局)批准登记成为在上市制剂使用的原料药。诚如本公司日期分别为2025年6月30日及2024年12月27日的公告所载，本集团已取得国家药监局有关呋塞米片及呋塞米注射液的药品生产注册批件。呋塞米主要用于治疗各种水肿性疾病、高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2629086028?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-21 16:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629086028","market":"fut","top_or_hot":-1,"title":"石四药集团(02005)：呋塞米获国家药监局批准登记成为在上市制剂使用的原料药","media":"智通财经","content":"<div>\n<p>智通财经APP讯，石四药集团(02005)发布公告，本集团的呋塞米已获中国国家药品监督管理局(国家药监局)批准登记成为在上市制剂使用的原料药。诚如本公司日期分别为2025年6月30日及2024年12月27日的公告所载，本集团已取得国家药监局有关呋塞米片及呋塞米注射液的药品生产注册批件。呋塞米主要用于治疗各种水肿性疾病、高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1431260.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>石四药集团(02005)：呋塞米获国家药监局批准登记成为在上市制剂使用的原料药</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n石四药集团(02005)：呋塞米获国家药监局批准登记成为在上市制剂使用的原料药\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-21 16:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1431260.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，石四药集团(02005)发布公告，本集团的呋塞米已获中国国家药品监督管理局(国家药监局)批准登记成为在上市制剂使用的原料药。诚如本公司日期分别为2025年6月30日及2024年12月27日的公告所载，本集团已取得国家药监局有关呋塞米片及呋塞米注射液的药品生产注册批件。呋塞米主要用于治疗各种水肿性疾病、高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1431260.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02005","symbol_name":"石四药集团","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1431260.html","article_id":"2629086028","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2629086028","pubTimestamp":1776760377,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，石四药集团(02005)发布公告，本集团的呋塞米已获中国国家药品监督管理局(国家药监局)批准登记成为在上市制剂使用的原料药。诚如本公司日期分别为2025年6月30日及2024年12月27日的公告所载，本集团已取得国家药监局有关呋塞米片及呋塞米注射液的药品生产注册批件。呋塞米主要用于治疗各种水肿性疾病、高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及急性药物毒物中毒(如巴比妥类药物中毒)，及预防急性肾功能衰竭。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02005":"石四药集团","IPOS":"Renaissance International IPO ETF","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","BK1191":"制药"},"translate_title":"Shi Si Yao Group (02005): Furosemide was approved by the State Food and Drug Administration for registration as an API for use in listed preparations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPOS":1.5,"02005":1.5},"content_text":"智通财经APP讯，石四药集团(02005)发布公告，本集团的呋塞米已获中国国家药品监督管理局(国家药监局)批准登记成为在上市制剂使用的原料药。诚如本公司日期分别为2025年6月30日及2024年12月27日的公告所载，本集团已取得国家药监局有关呋塞米片及呋塞米注射液的药品生产注册批件。呋塞米主要用于治疗各种水肿性疾病、高血压、高钾血症及高钙血症、稀释性低钠血症、抗利尿激素分泌过多症(SIADH)及急性药物毒物中毒(如巴比妥类药物中毒)，及预防急性肾功能衰竭。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629086028","isCrawlerRequest":true}